PMDD affects an estimated 3 to 8% of women of reproductive age, according to clinical research
PMDD Treatment in La Crosse, WI: Relief for Premenstrual Depression That Disrupts Your Life
Premenstrual dysphoric disorder is a serious mood disorder, not just bad PMS. IV ketamine therapy and Spravato offer rapid, neurologically distinct relief for PMDD and the severe depression and anxiety it produces, particularly when SSRIs and hormonal treatments haven't worked.
PMDD Is Not PMS. And You Deserve to Be Taken Seriously.
Premenstrual dysphoric disorder affects approximately 3 to 8% of women in their reproductive years. It’s a clinically recognized mood disorder listed in the DSM-5, characterized by severe depression, anxiety, irritability, and emotional volatility in the days before menstruation that are significant enough to disrupt daily functioning, relationships, and quality of life. Every month.
PMDD is not a sensitivity issue or an inability to cope. It’s a neurobiological condition rooted in an abnormal brain response to normal hormonal fluctuations. For women with PMDD, the hormonal shifts of the luteal phase trigger a cascade of mood symptoms that can feel completely overwhelming and entirely out of proportion to life circumstances. That’s the point: the brain’s response is the problem, not the circumstances.
At Relevate Ketafusion, we offer IV ketamine therapy and FDA-approved Spravato for women whose PMDD-related depression and anxiety haven’t responded adequately to SSRIs, hormonal treatments, or other conventional approaches. Both treatments act on the brain’s glutamate system, often producing meaningful relief within hours to days rather than weeks.
Understanding PMDD: A Brain Disorder That Follows a Hormonal Clock
PMDD develops in the luteal phase of the menstrual cycle, typically in the one to two weeks before menstruation. It resolves shortly after menstruation begins. This cyclical pattern distinguishes it from other mood disorders, but the severity of symptoms is fully comparable to major depressive disorder and generalized anxiety disorder at their most acute.
The underlying mechanism involves abnormal sensitivity in the brain’s response to progesterone and its metabolite allopregnanolone, a neurosteroid that typically has calming effects through GABA receptors. In women with PMDD, this system is dysregulated in ways that produce mood destabilization rather than calm during the luteal phase. This is a biological difference, not a psychological one, which is why purely psychological approaches often have limited impact.
Ketamine therapy’s relevance for PMDD lies primarily in its ability to rapidly address the severe depression, anxiety, and emotional dysregulation that PMDD produces, particularly when those symptoms have a treatment-resistant quality even within the context of the cycle. The glutamate system, which ketamine targets, is increasingly recognized as playing a role in the neurobiological mechanisms of PMDD.
Hear from Those Who've Found Hope
Call us
(608) 518-3915Address
2309 State Road La Crosse, WI 54601
Working hours
Mon-Thu: 7:30 am - 7:30 pm
Fri-Sat: 7:30 am - 12:30 pm
Book Your Consultation
Fill out the form below, and we’ll contact you shortly.
PMDD-Related Conditions We Treat
PMDD rarely travels alone. The severe mood symptoms it produces frequently overlap with and compound other clinical conditions. Ketamine therapy and Spravato are most directly relevant for the depression, anxiety, and emotional dysregulation at PMDD's core.
Treatment-Resistant PMDD Depression
For women whose PMDD-related depression hasn't responded to SSRIs, hormonal treatments, or other conventional approaches, both IV ketamine and Spravato offer a neurologically distinct alternative. Spravato's FDA approval for treatment-resistant depression makes it a well-validated option, and its rapid onset means it can provide relief within the compressed timeline of a luteal phase rather than requiring weeks to build up.
PMDD with Suicidal Ideation
Depression doesn't only emerge after delivery. Peripartum Severe PMDD is associated with elevated rates of suicidal ideation, particularly during the worst days of the luteal phase. Spravato holds an FDA approval specifically for major depressive disorder with active suicidal ideation or behavior, making it a directly indicated, fast-acting option for this clinical picture. If you or someone you love is experiencing suicidal thoughts, please call or text 988. or antenatal depression develops during pregnancy and can be just as severe as PPD. Treatment during pregnancy requires careful clinical judgment, and our medical team, led by Dr. Howard Schumaker, approaches each case individually to determine the safest, most effective path forward.
PMDD with Anxiety
Anxiety is one of the hallmark features of PMDD, often presenting as intense irritability, tension, and a feeling of being on edge that can be difficult to distinguish from generalized anxiety disorder during the luteal phase. Ketamine therapy's rapid calming effect on overactive anxiety circuits can provide meaningful relief that SSRIs, which require consistent blood levels to be effective, often struggle to deliver within the cyclical window of PMDD.
PMDD with Co-Occurring Depression or Anxiety Disorders
Women with pre-existing depression or anxiety disorders frequently experience dramatic worsening during the luteal phase, a pattern sometimes called premenstrual exacerbation. When existing conditions and PMDD reinforce each other in this way, standard treatment often falls short because it's designed for stable symptom levels rather than cyclical intensification. Ketamine therapy's rapid action can address both the baseline condition and the monthly worsening.
Perimenopausal Mood Dysregulation
As women enter perimenopause, hormonal fluctuations become more erratic and severe. For women with a history of PMDD, this transition can bring intensified mood symptoms that don't follow the predictable cyclical pattern of PMDD but share its neurobiological roots. Ketamine therapy's ability to rapidly address depression and anxiety makes it relevant for this perimenopausal presentation as well.
Your PMDD Treatment Journey at Relevate Ketafusion
From your first conversation to your last session, we're with you at every step.
01
Initial Consultation
Your journey starts with a virtual consultation. We'll talk through your PMDD history, your cycle patterns, the treatments you've tried, and what you're hoping to achieve. We'll conduct a thorough mental health screening and medical clearance review, and we'll discuss how ketamine therapy fits within your cycle, including timing strategies that can maximize the benefit within the luteal window.
02
Personalized Treatment Plan
We build your plan around your specific clinical picture, cycle patterns, and goals. For PMDD, treatment timing is part of the strategy. We'll map out your recommended number of sessions, the most effective timing within your cycle, and how we'll track your response across multiple cycles to assess progress. We'll also discuss how ketamine therapy fits alongside any other treatments you're receiving.
03
Treatment Sessions
Every session takes place in a private, calm treatment room with ambient lighting and soothing music. Our medical team stays present throughout, monitoring your vitals and your comfort in real time. Most patients describe the experience as peaceful. Plan to have someone drive you home afterward.
04
Integration and Ongoing Monitoring
We track your response carefully across cycles and adjust your plan as needed. For PMDD, assessing progress means looking at symptom severity, duration, and functional impact across multiple cycles rather than just immediately after treatment. We'll develop a maintenance approach that fits your life and your cycle, sustaining the relief you've built.
Our PMDD Treatments: IV Ketamine and Spravato
We offer two clinically validated, rapid-acting treatments for PMDD-related depression and anxiety. Your provider will help determine the right fit based on your diagnosis, history, cycle patterns, and goals.
IV Ketamine Therapy
Administered directly into the bloodstream through a small IV line, ketamine infusions offer precise dosing and immediate effect. Sessions typically last 40 to 60 minutes in a private, calm treatment room with continuous medical supervision. IV ketamine's rapid onset makes it particularly relevant for PMDD, where the window of severe symptoms is compressed into a predictable phase of the cycle. It's a self-pay treatment and not covered by insurance.
Learn More
Spravato (Esketamine) Therapy
FDA-approved for treatment-resistant depression and MDD with suicidal ideation, Spravato works on the same glutamate pathway as IV ketamine and offers a well-validated option for PMDD-related depression that hasn't responded to conventional treatment. You self-administer the nasal spray in our clinic under direct medical supervision, followed by a required monitoring period. Sessions last approximately two hours. Spravato is covered by most major insurance plans.
Learn More
The Science Behind Ketamine for PMDD
PMDD’s neurobiological roots involve an abnormal response to progesterone metabolites in the brain, particularly their interaction with GABA receptors. In women without PMDD, allopregnanolone, a byproduct of progesterone, has calming, anxiolytic effects. In women with PMDD, the same neurosteroid appears to have the opposite effect, triggering mood destabilization during the luteal phase.
Ketamine targets the glutamate system, a different neurological pathway than both GABA and serotonin. This makes it neurologically distinct from SSRIs (serotonin) and from the mechanisms implicated in PMDD’s hormonal dysregulation. Rather than trying to correct the hormonal response itself, ketamine addresses the downstream effects: the severe depression, anxiety, and emotional dysregulation that PMDD produces, rapidly and effectively.
Research on ketamine specifically for PMDD is still developing, but the evidence base for its rapid effects on treatment-resistant depression and anxiety, which are the core clinical features of severe PMDD, is well-established. We’ll discuss the current evidence honestly during your consultation.
Why Choose Relevate Ketafusion for PMDD Treatment
01
Rapid Relief That Works Within the Luteal Window
PMDD operates on a compressed timeline. SSRIs, which require weeks to reach therapeutic levels, are poorly suited to a condition where the worst symptoms arrive and resolve within days. Ketamine therapy’s rapid onset makes it far better matched to PMDD’s cyclical nature, offering meaningful relief within hours to days of treatment.
02
The Only IV Ketamine Clinic in the Coulee Region
Relevate Ketafusion is the only provider in the La Crosse area offering IV ketamine infusions. The nearest alternative is over two hours away. We built this clinic so that women in our community could access this level of care without a burdensome drive added to an already difficult month.
03
Spravato Covered by Insurance
Spravato is covered by most major insurance plans for treatment-resistant depression. Our team verifies your coverage before your first session and handles prior authorization. For IV ketamine, transparent self-pay pricing is available with HSA/FSA acceptance and CareCredit financing.
04
A Team That Takes Women's Mental Health Seriously
PMDD is a condition that has historically been minimized, misdiagnosed, or dismissed. Our team treats it with the clinical seriousness it deserves. Dr. Schumaker’s dual board certifications in Family and Emergency Medicine bring a comprehensive medical perspective. Robyn Brown’s personal experience with anxiety, combined with her dual FNP and PMHNP certifications, grounds her approach in both clinical expertise and genuine empathy for what it means to live with a cycling mood disorder.
05
Continuous Medical Supervision at Every Session
Every session happens under direct medical supervision with continuous monitoring. You’re never alone, and our team stays present and attentive throughout every visit. That level of care is non-negotiable at Relevate.
06
Founded by Someone Who Knows What It Means to Keep Searching for Relief
Tina Schumaker built Relevate after her own experience with treatment-resistant depression and PTSD. She understands the exhaustion of trying every available option and still not feeling better. That experience shapes how this clinic treats every patient who comes through its doors, especially those whose conditions have been minimized or undertreated elsewhere.
Blogs
Insights & Resources
Explore articles that empower your path to wellness.
March 25, 2026
Hope Beyond Traditional Antidepressants: Exploring New Paths to Healing
March 18, 2026
The Role of Integration After Ketamine Sessions
March 11, 2026
Understanding Dissociation: Why Some People Experience It and How It Is Managed During Treatment